SCHEMBL6175976

SCHEMBL6175976

CNS(=O)(=O)Nc1cc(CC2(C)NC(=O)N(c3ccc(OC(F)(F)F)cc3)C2=O)ccn1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 10/20 0.41
RAF1 P04049 1/20 0.36
MAP2K1 Q02750 1/20 0.36
ITGAL P20701 1/20 0.35
AR P10275 2/20 0.35
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 1/20 0.33
CYP3A4 P08684 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
GPR139 Q6DWJ6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169398 0.91 IGF1R (0.49) IGF1RITGALARPOLBL3MBTL1
SCHEMBL6173148 0.90 IGF1R (0.40) IGF1RITGALARTSHRKMT2A
SCHEMBL6175034 0.89 IGF1R (0.40) IGF1RITGALTSHRKMT2A
SCHEMBL6172079 0.89 IGF1R (0.47) IGF1RITGALARPOLBL3MBTL1
SCHEMBL6173180 0.89 IGF1R (0.40) IGF1RITGALARPOLBL3MBTL1
SCHEMBL6176131 0.87 SMN1; SMN2 (0.39) IGF1RARTSHRKMT2AMAPT
SCHEMBL6174982 0.86 IGF1R (0.56) IGF1RITGAL
SCHEMBL6222480 0.86 MAPT (0.46) IGF1RITGALPOLBMAPTCYP2C9
SCHEMBL6176348 0.82 IGF1R (0.40) IGF1RARPOLBL3MBTL1TSHR
SCHEMBL6175657 0.82 IGF1R (0.45) IGF1RITGALARPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed